Italian Economic Diplomacy 15 January: breaking news from around the world
SWITZERLAND – Angelini Pharma acquires Swiss company Arvelle Therapeutics. Italian company Angelini Pharma, part of Angelini Group, has entered into an agreement to acquire the Swiss pharmaceutical company Arvelle Therapeutics, responsible for the development and marketing in Europe of the new anti-seizure drug cenobamate. The agreement is worth over 950 million euros and, as emphasised […]
Read more
